Carbapenem resistance due to New Delhi Metallobetalactamase-1 (NDM-1) is becoming a global menace. Even though it has been claimed that this gene originated in New Delhi, [1] there is a paucity of literature on NDM-1 from healthcare centres in New Delhi itself. The need of the hour is to [1] quantify the burden of carbapenem resistance caused by NDM-1, [2] to review its change over time and [3] to evaluate new therapeutic options.
We undertook a study with an interest in local epidemiology, in a 2000-bedded tertiary care referral hospital in New Delhi that caters to an annual inpatient load of more than 58,000. Consecutive clinical specimens of blood from inpatients suffering from septicaemia caused by enterobacteriaceae during 2 months, January 2012 and January 2013, were the specimens under study.
The method of detection of the bla NDM-1 gene was conventional polymerase chain reaction (PCR), followed by sequencing of the 475bp amplicon. A known bla NDM-1 -positive Klebsiella pneumoniae strain was used as the positive control, while deoxyribonucleic acid (DNA) This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. Indian Journal of Medical Microbiology vol. 33, No. 4 extracted from Escherichia coli 25922 was used as the negative control for this study.
Nine consecutive enterobacteriaceae isolates were cultured from septicaemic patients in January 2012. None was carbapenemase-, MBL (Metallo-beta-lactamase)-or NDM-1-positive. Three (33%) were ESBL (Extended spectrum beta lactamase) producers.
Fifteen consecutive isolates were obtained in January 2013. Nine (60%) were ESBL and six (40%) were carbapenemase producers. While no resistance against meropenem was detected in January 2012, the figure rose to 40% in January 2013. Three Klebsiella pneumoniae were NDM-1-positive [ Figure 1 ] and susceptible to colistin by E-test. One hundred percent colistin susceptibility has been previously reported from Haryana. [2] Tigecycline resistance seen in a single strain in our study Minimal inhibitory concentration (MIC = 2 µg/ml) is an alarming indication of the shrinking therapeutic options for the management of such bla NDM-1 -positive strains. Tigecycline resistance of 06.81% has been previously reported from Chennai [2] and 27.27% from the SENTRY study. [3] Thus, a sharp rise in carbapenem resistance and NDM-1 production was noticed in the 1-year interval. Two of the three NDM-1-positive isolates had been obtained from infants. Tigecycline resistance was also documented. Antimicrobial stewardship backed by good clinician-laboratory communication is the only way forward. like to acknowledge Dr. Rafael Canton and Dr. Maria Isabel Morosini, Ramon Y Cajal Hospital, Madrid, Spain, for providing control strains required for modified Hodge test. We are extremely grateful to Dr. Vikas Manchanda, Head of department of Microbiology, CNBC, New Delhi for providing the blaNDM-1-positive control strain of Klebsiella pneumonia. [4] Financial support and sponsorship Nil.
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